Anagrelide and cardiovascular events. Much ado about nothing?

dc.contributor.authorBesses, Carlosspa
dc.contributor.authorMartínez Sellés Oliveria Soares, Manuel
dc.date.accessioned2013-11-27T17:25:49Z
dc.date.available2013-11-27T17:25:49Z
dc.date.issued2011spa
dc.description.impact2.923 JCR (2011) Q2, 27/68 Hematology, 80/196 Oncologyspa
dc.identifier.citationBesses, C., & Martínez-Sellés, M. (2011). Anagrelide and cardiovascular events. Much ado about nothing? Leukemia Research, 35(12), 1543-1544.spa
dc.identifier.doi10.1016/j.leukres.2011.07.031spa
dc.identifier.issn01452126spa
dc.identifier.urihttp://hdl.handle.net/11268/214
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessen
dc.subject.unescoEnfermedad cardiovascularspa
dc.titleAnagrelide and cardiovascular events. Much ado about nothing?spa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationa14a4cbe-6878-47e7-8b7b-ffdd4a82573a
relation.isAuthorOfPublication.latestForDiscoverya14a4cbe-6878-47e7-8b7b-ffdd4a82573a

Files